|
|
 |
 |
| |
|
|
|
| |
 |
| |
 |
|
A broad-spectrum antibacterial agent containing
levofloxacin, a
fluoroquinolone active
against a wide range
of Gram-positive
and Gram-negative
pathogens, and some
anaerobes. Levox
is indicated for
acute sinusitis,
acute exacerbation
of bacterial bronchitis,
community-acquired
pneumonia, nosocomial
pneumonia, skin and
skin structure infections,
urinary tract infections
and pyelonephritis.
The oral tablets
come in strengths
of 250 mg, 500
mg and 750 mg levofloxacin,
to be administered
once daily for 5-14
days in adults, according to the condition.
Levox™ is also
available in
vials containing
500 mg/100 mL levofloxacin
solution for intravenous
drip infusion, delivered
at 500-750 mg every
24 hours, for 3-14
days, as needed.
Detailed Product Information:
Levofloxacin Levox 250mg / 500mg
Tablets & 500mg I.V.>>
Levofloxacin
Levox 750mg
Tablet >>
|
| |
|
 |
|
|
|
 |
 |
|
A fluoroquinolone antibacterial agent active
against a wide range
of Gram-positive
and Gram-negative
bacteria and some
anaerobes. The orally
administered tablets
contain 250 mg, 500
mg or 750 mg levofloxacin,
indicated for the
treatment of acute
sinusitis, acute
exacerbation of bacterial
bronchitis, community-acquired
pneumonia, skin and
skin structure infections,
urinary tract infections,
pyelonephritis and
nosocomial pneumonia.
The recommended adult
dose is 250-500 mg
every 24 hours for
5-14 days. Floxel™ is also available in vials
containing 500
mg/100 mL levofloxacin
solution for intravenous
drip infusion, delivered
at 500-750 mg every
24 hours, for 3-14
days, as needed.
Detailed Product Information:
Levofloxacin Floxel 250mg / 500mg Tablet &
500mg I.V. >>
Levofloxacin Floxel 750mg Tablet >>
|
| |
|
|
|
|
|
 |
 |
|
A fluoroquinolone antibacterial agent active against a wide
range of Gram-positive and Gram-negative bacteria and some anaerobes. The
orally administered tablets contain 200 mg or 400 mg ofloxacin, indicated for
the treatment of lower respiratory tract infections, sexually transmitted
diseases, skin and skin structure infections, and urinary tract and enteric
infections. The recommended dose (200-400 mg every 12 hours) and duration of
treatment (ranging from 1 day to 6 weeks) should be determined according to the
condition. Inoflox® is also available in vials containing 200 mg/100mL
ofloxacin for intravenous drip infusion at 100-400 mg every 12 hours for 1-10
days, as needed.
Detailed Product Information:
Ofloxacin Inoflox 200mg & 400mg
Tablet >>
Ofloxacin Inoflox
200mg/100mL I.V. >>
|
| |
|
|
 |
|
A sterile aqueous solution for otic use, containing 3 mg/mL
(0.3%) ofloxacin, a wide spectrum antibacterial agent of the fluoroquinolone
class providing coverage against Gram-positive and Gram-negative bacteria.
Inoflox eardrops are indicated for the treatment of acute and chronic purulent
otitis media, and acute exacerbation of chronic purulent otitis
media and otitis externa. The recommended dose is 3-5 drops
(for adults) or 1-3 drops (for children) twice daily for 7-14 days.
Detailed Product Information >>
|
| |
|
|
 |
|
An anti-fibrinolytic agent, indicated for prompt and effective
control of hemorrhage in various surgical procedures, obstetrical and
gynecological conditions (postpartum hemorrhage), dental surgery and tooth
extraction, and medical conditions (epistaxis, hematuria, hemorrhaging peptic
ulcer, etc.) Hemostan® contains tranexamic acid, which exhibits
anti-fibrinolytic effect thereby promoting fibrin and clot stability. It is
available in 250 mg and 500 mg capsules, to be taken every 6 to 8 hours. The
ampules, containing 250 mg/2.5 mL and 500 mg/5 mL of tranexamic acid, can be
administered by I.V./I.M. injection or by intravenous drip infusion as required
during or after surgery.
Detailed Product Information:
Tranexamic Acid Hemostan >>
|
| |
|
|
|
|
|
 |
 |
|
A fluoroquinolone antibacterial agent active
against a wide range of Gram-positive and Gram-negative bacteria
and some anaerobes. Qinolon™
is indicated
for the treatment of adults with lower respiratory tract infections,
sexually transmitted diseases, skin and skin structure infections,
and urinary tract
and enteric infections. The orally administered tablets contain
200 mg or 400 mg ofloxacin. The recommended dose (200-400 mg
every 12
hours) and duration
of treatment (ranging from 1 day to 6 weeks) should be determined
according to the condition. Qinolon™ is also available in vials
containing 200 mg/mL ofloxacin solution for intravenous drip
infusion,
delivered at
100-400 mg every 12 hours for 1-10 days, as needed.
Detailed Product Information:
Ofloxacin Qinolon 200mg Tablet >>
Ofloxacin Qinolon
400mg Tablet >>
Ofloxacin Qinolon 200mg/100mL I.V. >>
|
| |
|
|
|
| |
 |
|
|
|
|
